https://scholars.lib.ntu.edu.tw/handle/123456789/636913
Title: | Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan | Authors: | CHIN-HSIAO TSENG | Keywords: | multiple myeloma; pharmacoepidemiological study; pioglitazone; rosiglitazone; thiazolidinedione | Issue Date: | 26-Aug-2023 | Journal Volume: | 15 | Journal Issue: | 17 | Source: | Cancers | Abstract: | Thiazolidinedione (TZD) exerts anti-proliferative effects on multiple myeloma (MM) cells. However, there has not been any human study investigating the risk of MM associated with TZD use. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/636913 | ISSN: | 2072-6694 | DOI: | 10.3390/cancers15174276 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.